Combined Colon and Endometrial Cancer Screening in Women With HNPCC
To test the feasibility of combined colon and endometrial cancer screening in women with increased risk for colon and endometrial cancer.
To measure patient satisfaction for the combined procedure.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||A Pilot Study for Combined Colon and Endometrial Cancer Screening in Women at High-Risk for Colon and Endometrial Cancer|
- Feasibility to perform both colon and endometrial cancer screening at the time of colonoscopy in women at high risk for colon and endometrial cancer. [ Time Frame: 8 Years ] [ Designated as safety issue: No ]
|Study Start Date:||March 2002|
|Estimated Primary Completion Date:||May 2015 (Final data collection date for primary outcome measure)|
High Risk Group
Colon and/or Endometrial Cancer
Interview regarding perception of pain and the benefits and barriers to the combined screening.
Other Name: Survey
Women with certain medical conditions have an increased risk for colon and endometrial cancer. Currently, women go through separate screening procedures. Endometrial biopsies are performed at a separate visit to the gynecologist, and patients are not sedated for the procedure. This study will involve performing an endometrial biopsy while you are sedated for your colonoscopy.
Women who are able to have children must have a negative blood or urine pregnancy test before they can take part in this study.
As part of the study, you will be asked about your past experience with endometrial biopsy and colonoscopy. You will be asked about your perception of pain, your expectations, and the benefits and barriers to the combined screening.
You will then be sedated. The colonoscopy will be performed first by a gastroenterologist. This will be followed by the endometrial biopsy, which will be performed by a gynecologic oncologist.
A telephone interview will be performed two weeks after this procedure. The interview will last about 15 minutes. You will be asked about your perception of pain and the benefits and barriers to the combined screening.
This is an investigational study. A total of 50 women will take part in this study. All will be enrolled at M. D. Anderson.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00510796
|United States, Texas|
|UT MD Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Karen H. Lu, MD||M.D. Anderson Cancer Center|